Hypertriglyceridemia: A potential side effect of propofol sedation in critical illness

Intensive Care Medicine

Volumn 38, Issue 12, 2012, Pages 1990-1998

  Devaud, J C ^a,b   Berger, M M ^a   Pannatier, A ^a,b   Marques Vidal, P ^c   Tappy, L ^d   Rodondi, N ^d,e   Chiolero, R ^a   Voirol, P ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

Hypertriglyceridemia; ICU; Lipid metabolism; Nutrition; Propofol; Sedation

Indexed keywords

LIPID; PROPOFOL; PROPOFOL MCT FRESENIUS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

AGE; ARTICLE; BODY MASS; BRAIN INJURY; CALORIC INTAKE; CRITICAL ILLNESS; GLUCOSE INTAKE; HUMAN; HYPERTRIGLYCERIDEMIA; LIPID DIET; MAJOR CLINICAL STUDY; MULTIPLE TRAUMA; RISK FACTOR; SEDATION; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CRITICAL ILLNESS; DRUG CARRIERS; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; HYPNOTICS AND SEDATIVES; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PROPOFOL; PROSPECTIVE STUDIES; RISK FACTORS; SWITZERLAND;

EID: 84872077835     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2688-8     Document Type: Article

References (37)

1. Barrientos-Vega R, Mar. Sanchez-Soria M, Morales-Garcia C, Robas-Gomez A, Cuena-Boy R, Ayensa-Rincon A (1997) Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med 25:33-40
2. Marik PE (2006) Dyslipidemia in the critically ill. Crit Care Clin 22:151-159 viii (Pubitemid 43037115)
3. Mantel-Teeuwisse AK, Kloosterman JME, Maitland-van der Zee AH, Klungel OH, Porsius AJ, de Boer A (2001) Drug-induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels. Drug Saf 24:443-456 (Pubitemid 32458079)
4. Maxime V, Annane D (2005) Manifestations endocriniennes liées au sepsis. Réanimation 14:230-237
5. Bézie Y, Cattan V, Fractal LP, Lescol LP (2003) Comparaison des différentes statines: implications cliniques et choix thérapeutiques. MT Cardio 1:46-54
6. Crook MA (2000) Lipid clearance and total parenteral nutrition: the importance of monitoring plasma lipids. Nutrition 16:774-775
7. Shams MR, Tavassoli N, Plicaud H, Genestal M (2009) Incidence and risk factors of hypertriglyceridemia in the ICU. Crit Care Med 13:130
8. Llop J, Sabin P, Garau M, Burgos R, Perez M, Masso J, Cardona D, Sanchez Segura JM, Garriga R, Redondo S, Sagales M, Ferrer D, Pons M, Vuelta M, Fabregas X, Vitales M, Casasin T, Martinez J, Morato L, Soler M (2003) The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr 22:577-583 (Pubitemid 37455726)
9. Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, Paccaud F, Preisig M, Song KS, Yuan X, Danoff TM, Stirnadel HA, Waterworth D, Mooser V, Waeber G, Vollenweider P (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8:6
10. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G (2004) Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metabol 89:219-226 (Pubitemid 38183885)
11. Vergès B (2007) Physiopathologie de la dyslipidémie du syndrome métabolique et du diabète de type 2. Nut Clin Metabol 21:9-16
12. Chien JY, Jerng JS, Yu CJ, Yang PC (2005) Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis. Crit Care Med 33:1688
13. Singer P, Berger MM, Van den Berghe G, Biolo G, Calder P, Forbes A, Griffiths R, Kreyman G, Leverve X, Pichard C, ESPEN (2009) ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr 28:387-400
14. Druml W, Fischer M, Pidlich J, Lenz K (1995) Fat elimination in chronic hepatic failure: long-chain vs mediumchain triglycerides. Am J Clin Nutr 61:812-817
15. Tanaka S, Miki T, Hsieh ST, Kim JI, Yasumoto T, Taniguchi T, Ishikawa Y, Yokoyama M (2003) A case of severe hyperlipidemia caused by long-term tube feedings. J Atheroscler Thromb 10:321-324
16. Theilen HJ, Adam S, Albrecht MD, Ragaller M (2002) Propofol in a medium-and long-chain triglyceride emulsion: pharmacological characteristics and potential beneficial effects. Anesth Analg 95:923-929 (table of contents)
17. Al Riyami NB, Frohlich J (2008) Extreme hypertriglyceridemia following intravenous heparin infusion. Clin Biochem 41:907-909
18. Nasstrom B, Olivecrona G, Olivecrona T, Stegmayr BG (2001) Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted. J Lab Clin Med 138:206-213 (Pubitemid 32812234)
19. Que YA, Bracco D, Chioléro RL (2007) Aspects métaboliques et nutritionnels des catécholamines et des glucocortiöides Traité de nutrition artificielle de l'adulte. Springer, Berlin, pp 183-191
20. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM (2003) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 41:159
21. Calandra T, Cohen J (2005) The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med 33:1538
22. Berger MM, Revelly JP, Wasserfallen JB, Schmid A, Bouvry S, Cayeux MC, Musset M, Maravic P, Chiolero RL (2006) Impact of a computerized information system on quality of nutritional support in the ICU. Nutrition 22:221-229 (Pubitemid 43261518)
23. Soguel L, Revelly JP, Schaller MD, Longchamp C, Berger MM (2012) Energy deficit and length of hospital stay can be reduced by a two-step quality improvement of nutrition therapy: The intensive care unit dietitian can make the difference. Crit Care Med 40:412
24. Armitage P, Berry G, Matthews JNS (2002) Statistical methods in medical research. Wiley, London
25. McLeod G, Dick J, Wallis C, Patterson A, Cox C, Colvin J (1997) Propofol 2 % in critically ill patients: effect on lipids. Crit Care Med 25:1976-1981 (Pubitemid 28007233)
26. Baker MT, Naguib M (2005) Propofol: the challenges of formulation. Anesthesiology 103:860-876 (Pubitemid 41415536)
27. Cremer OL (2009) The propofol infusion syndrome: more puzzling evidence on a complex and poorly characterized disorder. Crit Care 13:1012
28. Devlin JW, Mallow-Corbett S, Riker RR (2010) Adverse drug events associated with the use of analgesics, sedatives, and antipsychotics in the intensive care unit. Crit Care Med 38:S231
29. Vasile B, Rasulo F, Candiani A, Latronico N (2003) The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med 29:1417-1425 (Pubitemid 37153585)
30. Devlin JW, Lau AK, Tanios MA (2005) Propofol-associated hypertriglyceridemia and pancreatitis in the intensive care unit: an analysis of frequency and risk factors. Pharmacotherapy 25:1348-1352 (Pubitemid 41407632)
31. Roth MS, Martin AB, Katz JA (1997) Nutritional implications of prolonged propofol use. Am J Health Syst Pharm (AJHP) 54:694
32. Petit V, Niot I, Poirier H, Besnard P (2007) Absorption intestinale des acides gras: faits et incertitudes. Nut Clin Metabol 21:38-45 (Pubitemid 46528714)
33. Chambrier C, Lauverjat M, Bouletreau P (2006) Emulsions lipidiques: indication des différentes émulsions lipidiques. Nut Clin Metabol 20:73-78
34. Nordenstrom J, Carpentier YA, Askanazi J, Robin AP, Elwyn DH, Hensle TW, Kinney JM (1982) Metabolic utilization of intravenous fat emulsion during total parenteral nutrition. Ann Surg 196:221-231 (Pubitemid 12038895)
35. Tappy L, Berger MM, Schwarz JM, Schneiter P, Kim S, Revelly JP, Chiolero R (2006) Metabolic effects of parenteral nutrition enriched with n-3 polyunsaturated fatty acids in critically ill patients. Clin Nutr 25:588-595 (Pubitemid 44070591)
36. Chiarla C, Giovannini I, Giuliante F, Zadak Z, Vellone M, Ardito F, Clemente G, Murazio M, Nuzzo G (2010) Severe hypocholesterolemia in surgical patients, sepsis, and critical illness. J Crit Care 25:361.e7-361.e12
37. Nielsen A, Nielsen R, Riis A, Johnsen S, Sorensen H, Thomsen R (2012) The impact of statin use on pneumonia risk and outcome: a combined populationbased case-control and cohort study. Crit Care 16:R122